Japanese wholesalers join up in $2b deal

As was rumored yesterday, Japan's biggest drug wholesaler, Mediceo Paltac, plans a buyout of its closest rival Alfresa in a $2 billion deal that will create a company more than twice as large of its next largest competitor. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.